Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascertain is a healthcare-focused venture studio and company creator established as a joint venture between the Mount Sinai Health System and Eurofins Scientific. The company is dedicated to accelerating the development and commercialization of innovative healthcare technologies, with a primary focus on AI-driven diagnostics and personalized medicine. By leveraging Mount Sinai's extensive clinical data and research expertise alongside Eurofins' global leadership in laboratory testing and commercialization, Ascertain identifies and scales high-impact solutions to address significant unmet medical needs. The entity operates as a platform for launching new startups that integrate advanced data science with clinical applications to improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ascertain.